Valence Advantage Life Sciences Fund Investments

Valence Advantage Life Sciences Fund has invested in 5 companies and its latest investment was CalciMedica on Mar 10, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

CalciMedica is a California-based biopharmaceutical company that researches and develops novel therapies for the treatment of chronic inflammatory diseases.
$21M
Mar 10, 2021
-
CalciMedica is a California-based biopharmaceutical company that researches and develops novel therapies for the treatment of chronic inflammatory diseases.
$17.2M
May 21, 2020
-
Invuity is a provider of photonics-based illumination and visualization solutions for gynaecology, spine, orthopedic and cardiothoracic surgeries.
$22.9M
Feb 05, 2015
-
Invuity is a provider of photonics-based illumination and visualization solutions for gynaecology, spine, orthopedic and cardiothoracic surgeries.
$36M
Mar 03, 2014
-
Invuity is a provider of photonics-based illumination and visualization solutions for gynaecology, spine, orthopedic and cardiothoracic surgeries.
$25M
Jun 13, 2012
-

Frequently Asked Questions about Valence Advantage Life Sciences Fund

  1. What is Valence Advantage Life Sciences Fund investing in?

    Valence Advantage Life Sciences Fund has invested in 5 companies including CalciMedica, CalciMedica and Invuity
  2. What company did Valence Advantage Life Sciences Fund invest in?

    Valence Advantage Life Sciences Fund invested in a total 5 companies including CalciMedica, CalciMedica and Invuity
  1. What are the top 5 investments by Valence Advantage Life Sciences Fund?

    The top companies in which Valence Advantage Life Sciences Fund invested are CalciMedica, CalciMedica, Invuity, Invuity and Invuity